Urgent response is needed to address the stimulant-fentanyl related overdose crisis

• by Rosalina Mills, Oluwole Jegede, Srinivas B. Muvvala

• March 17, 2026

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

• by Kathryn Wighton

• May 29, 2026

• 3 min

6 takeaways from STAT’s investigation into the U.S. alcohol epidemic

• by Isabella Cueto, Lev Facher

• May 12, 2026

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

• by Kathryn Wighton

• May 27, 2026

• 5 min